title: Management of methamphetamine abuse and dependence.
abstract: Preliminary implications for evidence-based treatments and future practice may be drawn from new research findings that inspire a fresh view of methamphetamine dependence and associated medical consequences. Current user populations include increasingly impacted subgroups (ie, youths, women, men who have sex with men, and rural residents); complex consequences of methamphetamine abuse among these subgroups require additional efforts involving contextual understanding of characteristics and needs to develop effective treatments. The neurobiological data on cellular activity of methamphetamine taken with findings from neuroimaging studies indicate potential targets for pharmacologic interventions. In early trials, several candidate medications--bupropion, modafinil, and, to a lesser extent, baclofen--have shown promise in treating aspects of methamphetamine dependence, including aiding memory function necessary to more effectively participate in and benefit from behavioral therapies. Clinicians and researchers must interact to efficiently address the problems of methamphetamine dependence, a major drug problem in the United States and the world.
authors.affiliation: Integrated Substance Abuse Programs, David Geffen School of Medicine at UCLA, University of California-Los Angeles, 11075 Santa Monica Boulevard, Suite 200, Los Angeles, CA 90025, USA. lwalter@ix.netcom.com
authors.forename: Walter
authors.initials: W
authors.lastname: Ling
authors.forename: Richard
authors.initials: R
authors.lastname: Rawson
authors.forename: Steve
authors.initials: S
authors.lastname: Shoptaw
authors.forename: Walter
authors.initials: W
authors.lastname: Ling
mesh_terms: D001418:Baclofen / Q000627:therapeutic use; D001559:Benzhydryl Compounds / Q000627:therapeutic use; D001921:Brain / Q000187:drug effects / Q000503:physiopathology; D016642:Bupropion / Q000627:therapeutic use; D003072:Cognition Disorders / Q000453:epidemiology / Q000503:physiopathology; D015928:Cognitive Behavioral Therapy; D006801:Humans; D008694:Methamphetamine / Q000009:adverse effects / Q000494:pharmacology; D000077408:Modafinil; D009415:Nerve Net / Q000187:drug effects; D013375:Substance Withdrawal Syndrome / Q000209:etiology; D019966:Substance-Related Disorders / Q000453:epidemiology / Q000534:rehabilitation* / Q000628:therapy
chemical_list: D001559:Benzhydryl Compounds; D016642:Bupropion; D008694:Methamphetamine; D001418:Baclofen; D000077408:Modafinil